Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer

World Journal of Gastroenterology

Volumn 18, Issue 19, 2012, Pages 2423-2429

  Luo, Deng ^a   Lu, Ming Liang ^a   Zhao, Gong Fang ^a   Huang, Hua ^a   Zheng, Meng Yao ^a   Chang, Jiang ^a   Lv, Lin ^a   Luo, Jin Bo ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Cell adhesion molecules; Gastric cancer; Metastasis; Popeye domain containing 3; Prognosis

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; POPDC 3 GENE; RETROSPECTIVE STUDY; STOMACH CANCER;

EID: 84861746152     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i19.2423     Document Type: Article

References (40)

1. Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G. Gastric cancer. J Natl Compr Canc Netw 2010; 8: 378-409
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249
3. Ye YW, Dong RZ, Zhou Y, Du CY, Wang CM, Fu H, Shi YQ. Prognostic analysis of familial gastric cancer in Chinese population. J Surg Oncol 2011; 104: 76-82
4. Chen JG, Zhu J, Zhang YH, Lu JH. Cancer survival in Qidong, China, 1992-2000. IARC Sci Publ 2011; (162): 43-53
5. Law SC, Mang OW. Cancer survival in Hong Kong SAR, China, 1996-2001. IARC Sci Publ 2011; (162): 33-41
6. Xishan H, Chen K, Min H, Shufen D, Jifang W. Cancer survival in Tianjin, China, 1991-1999. IARC Sci Publ 2011; (162): 69-84
7. Xiang YB, Jin F, Gao YT. Cancer survival in Shanghai, China, 1992-1995. IARC Sci Publ 2011; (162): 55-68
8. Thun M, Jemal A, Desantis C, Blackard B, Ward E. An overview of the cancer burden for primary care physicians. Prim Care 2009; 36: 439-454
9. Wang J, Yu JC, Kang WM, Ma ZQ. Treatment strategy for early gastric cancer. Surg Oncol 2011; Epub ahead of print
10. Hager HA, Bader DM. Bves: ten years after. Histol Histopathol 2009; 24: 777-787
11. Reese DE, Zavaljevski M, Streiff NL, Bader D. bves: A novel gene expressed during coronary blood vessel development. Dev Biol 1999; 209: 159-171
12. Andrée B, Hillemann T, Kessler-Icekson G, Schmitt-John T, Jockusch H, Arnold HH, Brand T. Isolation and characterization of the novel popeye gene family expressed in skeletal muscle and heart. Dev Biol 2000; 223: 371-382
13. Wada AM, Reese DE, Bader DM. Bves: prototype of a new class of cell adhesion molecules expressed during coronary artery development. Development 2001; 128: 2085-2093
14. Breher SS, Mavridou E, Brenneis C, Froese A, Arnold HH, Brand T. Popeye domain containing gene 2 (Popdc2) is a myocyte-specific differentiation marker during chick heart development. Dev Dyn 2004; 229: 695-702
15. Vasavada TK, DiAngelo JR, Duncan MK. Developmental expression of Pop1/Bves. J Histochem Cytochem 2004; 52: 371-377
16. Kim M, Jang HR, Haam K, Kang TW, Kim JH, Kim SY, Noh SM, Song KS, Cho JS, Jeong HY, Kim JC, Yoo HS, Kim YS. Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer. Carcinogenesis 2010; 31: 1685-1693
17. Santiago JM, Sasako M, Osorio J. [TNM-7th edition 2009 (UICC/AJCC) and Japanese Classification 2010 in Gastric Cancer. Towards simplicity and standardisation in the management of gastric cancer]. Cir Esp 2011; 89: 275-281
18. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010; 17: 3077-3079
19. Zeng Q, Zhao Y, Yang Y, Chen XX, Wang G, Zhang P, Cui Y, Su S, Li K. Expression of Cystatin C in human stomach neoplasms. Mol Med Report 2010; 3: 607-611
20. Ishigami S, Ueno S, Nishizono Y, Matsumoto M, Kurahara H, Arigami T, Uchikado Y, Setoyama T, Arima H, Yoshiaki K, Kijima Y, Kitazono M, Natsugoe S. Prognostic impact of CD168 expression in gastric cancer. BMC Cancer 2011; 11: 106
21. Hofmann M, Stoss O, Shi D, Büttner R, van de Vijver M, Kim W, Ochiai A, Rüschoff J, Henkel T. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology 2008; 52: 797-805
22. Geller SA, Dhall D, Alsabeh R. Application of immunohistochemistry to liver and gastrointestinal neoplasms: liver, stomach, colon, and pancreas. Arch Pathol Lab Med 2008; 132: 490-499
23. Nobili S, Bruno L, Landini I, Napoli C, Bechi P, Tonelli F, Rubio CA, Mini E, Nesi G. Genomic and genetic alterations influence the progression of gastric cancer. World J Gastroenterol 2011; 17: 290-299
24. Pandey R, Misra V, Misra SP, Dwivedi M, Kumar A, Tiwari BK. Helicobacter pylori and gastric cancer. Asian Pac J Cancer Prev 2010; 11: 583-588
25. Hatziapostolou M, Iliopoulos D. Epigenetic aberrations during oncogenesis. Cell Mol Life Sci 2011; 68: 1681-1702
26. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17: 330-339
27. Watanabe Y, Maekawa M. Methylation of DNA in cancer. Adv Clin Chem 2010; 52: 145-167
28. Corvalan AH, Maturana MJ. Recent patents of DNA methylation biomarkers in gastrointestinal oncology. Recent Pat DNA Gene Seq 2010; 4: 202-209
29. Knight RF, Bader DM, Backstrom JR. Membrane topology of Bves/Pop1A, a cell adhesion molecule that displays dynamic changes in cellular distribution during development. J Biol Chem 2003; 278: 32872-32879
30. Ripley AN, Osler ME, Wright CV, Bader D. Xbves is a regulator of epithelial movement during early Xenopus laevis development. Proc Natl Acad Sci USA 2006; 103: 614-619
31. Ripley AN, Chang MS, Bader DM. Bves is expressed in the epithelial components of the retina, lens, and cornea. Invest Ophthalmol Vis Sci 2004; 45: 2475-2483
32. Osler ME, Chang MS, Bader DM. Bves modulates epithelial integrity through an interaction at the tight junction. J Cell Sci 2005; 118: 4667-4678
33. Hager HA, Roberts RJ, Cross EE, Proux-Gillardeaux V, Bader DM. Identification of a novel Bves function: regulation of vesicular transport. EMBO J 2010; 29: 532-545
34. Gingold-Belfer R, Bergman M, Alcalay Y, Schlesinger H, Aravot D, Berman M, Salman H, Brand T, Kessler-Icekson G. Popeye domain-containing 1 is down-regulated in failing human hearts. Int J Mol Med 2011; 27: 25-31
35. Jayagopal A, Yang JL, Haselton FR, Chang MS. Tight junction-associated signaling pathways modulate cell proliferation in uveal melanoma. Invest Ophthalmol Vis Sci 2011; 52: 588-593
36. Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, Jordan CD, Kiviat NB, Vesselle H. DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2008; 17: 645-654
37. Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 2008; 25: 621-628
38. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28: 15-33
39. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010; 15: 117-134
40. Williams CS, Zhang B, Smith JJ, Jayagopal A, Barrett CW, Pino C, Russ P, Presley SH, Peng D, Rosenblatt DO, Haselton FR, Yang JL, Washington MK, Chen X, Eschrich S, Yeatman TJ, El-Rifai W, Beauchamp RD, Chang MS. BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma. J Clin Invest 2011; 121: 4056-4069